secwatch / observer
8-K filed March 8, 2024, 6:59 PM ET ticker SLS CIK 0001390478
leadership confidence high sentiment negative materiality 0.65

SELLAS terminates EVP General Counsel and SVP Chief Commercial Officer; reorganizes leadership

SELLAS Life Sciences Group, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Francomano

Senior Vice President and Chief Commercial Officer
SLS · SELLAS Life Sciences Group, Inc.
Effective
2024-03-31
Filed
March 8, 2024, 6:59 PM ET
In addition, on March 6, 2024, Robert Francomano, Senior Vice President and Chief Commercial Officer of the Company, was terminated without cause, effective March 31, 2024.
Departed

Barbara A. Wood

Executive Vice President, General Counsel and Corporate Secretary
SLS · SELLAS Life Sciences Group, Inc.
Effective
2024-04-15
Filed
March 8, 2024, 6:59 PM ET
On March 6, 2024, Barbara A. Wood, Executive Vice President, General Counsel and Corporate Secretary of SELLAS Life Sciences Group, Inc. (the “Company”), was terminated without cause, effective April 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert Francomano was terminated as Senior Vice President and Chief Commercial Officer at SELLAS Life Sciences Group, Inc..

Action
terminated
Role
Senior Vice President and Chief Commercial Officer
Exact text from the filing
In addition, on March 6, 2024, Robert Francomano, Senior Vice President and Chief Commercial Officer of the Company, was terminated without cause, effective March 31, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Barbara A. Wood was terminated as Executive Vice President, General Counsel and Corporate Secretary at SELLAS Life Sciences Group, Inc..

Action
terminated
Role
Executive Vice President, General Counsel and Corporate Secretary
Exact text from the filing
On March 6, 2024, Barbara A. Wood, Executive Vice President, General Counsel and Corporate Secretary of SELLAS Life Sciences Group, Inc. (the “Company”), was terminated without cause, effective April 15, 2024.
View on SEC.gov

SELLAS Life Sciences Group, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-24-032384
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.